Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  lorvotuzumab mertansine
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Lorvotuzumab Mertansine in Treating Patients with Refractory CD56-Expressing Hematological Malignancies
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2014-0926, NCI-2015-00683, NCT02420873
Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 13 months to 30 years
Trial IDs: ADVL1522, NCI-2015-00746, NCT02452554
Start Over